1. Startpage

Browsing by Author Theobald, Matthias

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 2 to 10 of 10 < previous 
PreviewIssue dateOnline publication dateTitleAuthor(s)
59139.pdf.jpg201910-Jul-2019CD11b regulates fungal outgrowth but not neutrophil recruitment in a mouse model of invasive pulmonary aspergillosisTeschner, Daniel; Cholaszczyńska, Anna; Ries, Frederic; Beckert, Hendrik; Theobald, Matthias; Grabbe, Stephan; Radsak, Markus; Bros, Matthias
woelfinger_pascal-cd52-negative_-20210816104941103.pdf.jpg202016-Aug-2021CD52-negative T cells predict acute graft-versus-host disease after an alemtuzumab-based conditioning regimenWölfinger, Pascal; Epp, Katharina; Schaefer, Lukas; Kriege, Diana; Theobald, Matthias; Bopp, Tobias; Wagner-Drouet, Eva-Maria
cure_rate_in_the_elderly_pati-20220822133007161.pdf.jpg202123-Aug-2022Cure rate in the elderly patients with diffuse large B cell lymphoma deteriorates after the age of 80 : results from a single-center surveyFreudenberger, Felix; Ohler, Anke; Theobald, Matthias; Hess, Georg
diagnosis_of_sinusoidal_obstr-20231215141401429.pdf.jpg20235-Jan-2024Diagnosis of sinusoidal obstruction syndrome : can biopsy be the key?Kriege, Oliver; Kreft, Andreas; Hauptrock, Beate; Wölfinger, Pascal; Theobald, Matthias; Wagner-Drouet, Eva-Maria
einflussfaktoren_auf_die_inzi-20231016202642147.pdf.jpg202313-Nov-2023Einflussfaktoren auf die Inzidenz chronischer Graft-versus-Host-Disease des Mundraums nach allogener hämatopoetischer StammzelltransplantationTheobald, Matthias; Müller-Franz, Kathleen Verena
a_phase_ii_trial_to_evaluate_-20230119110130294.pdf.jpg202219-Jan-2023A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma : final results of the prospective, multicentre GOAL trialHess, Georg; Hüttmann, Andreas; Witzens-Harig, Mathias; Dreyling, Martin H.; Keller, Ulrich; Marks, Reinhard; Ernst, Thomas; Pott, Christiane; Viardot, Andreas; Frontzek, Fabian; Trautmann, Marcel; Ruckes, Christian; Deuster, Oliver; Rosenwald, Andreas; Theobald, Matthias; Lenz, Goerg
pretransplant_plateletto_lymp-20230307124639943.pdf.jpg202218-Apr-2023Pre-transplant platelet-to-lymphocyte ratio predicts outcome after allogeneic hematopoietic stem cell transplantationWoelfinger, Pascal; Hauptrock, Beate; Kriege, Oliver; List, Agnes; Schmitt, Timo; Kuchen, Robert; Theobald, Matthias; Wagner-Drouet, Eva M.
struggling_with_extensive_inf-20221117150808587.pdf.jpg20224-Jan-2023Struggling with extensive informed consent procedures for cancer trials : is there even a benefit for the patients?Tilch, Marie-Kristin; Schranz, Melanie; Moringlane, Alice; Theobald, Matthias; Hess, Georg
targeting_the_melanomaassocia-20240214143735778.pdf.jpg202320-Feb-2024Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptorsKropp, Korbinian N.; Fatho, Martina; Huduti, Enes; Faust, Marilena; Lübcke, Silke; Lennerz, Volker; Paschen, Annette; Theobald, Matthias; Wölfel, Thomas; Wölfel, Catherine
Showing results 2 to 10 of 10 < previous